Nominees Announced for 2016-2017 Pioneers in Performance Awards for Latin...
FLAGSTAFF, Ariz. & SÃO PAULO W. L. Gore & Associates, Inc. (Gore) today announced the nominees and opening of voting for the 2016-2017 Pioneers in Performance Awards for Latin America at the...
View ArticleHutchison China MediTech Limited Announces Exercise of Overallotment Option
LONDON Hutchison China MediTech Limited (“Chi-Med”) (Nasdaq/AIM: HCM) announces that the underwriters of its offering of American depositary shares (“ADSs”) on the Nasdaq Global Select Market (the...
View Article2016-2017年度拉丁美洲表现先锋奖被提名者公布
亚利桑那州弗拉格斯塔夫和巴西圣保罗 (美国商业资讯) — W. L. Gore & Associates, Inc. (Gore)今天在巴西圣保罗召开的国际血管内外科大会(CICE) 2016年度研讨会上宣布了 2016-2017年度拉丁美洲表现先锋奖的被提名者和投票的启动。...
View Article2016~2017年「パフォーマンスのパイオニア賞(中南米)」の受賞候補者を発表
米アリゾナ州フラッグスタッフ & サンパウロ (ビジネスワイヤ) — W. L. Gore & Associates, Inc.(ゴア)は本日、サンパウロで開催中の「2016年血管内手術国際会議」(Congreso Internacional Cirugia Endovascular...
View ArticleSosei Subsidiary Heptares and Kymab Enter Strategic Collaboration to...
TOKYO Sosei Group Corporation (“Sosei”; TSE Mothers Index: 4565) today announces Heptares Therapeutics (“Heptares”), the wholly-owned subsidiary of Sosei, and Kymab Limited, a leading human...
View ArticleVitruvias Therapeutics and Sunny Pharmtech Expand Partnership to Co-Develop...
AUBURN, Ala. & TAIPEI, Taiwan Sunny Pharmtech Inc., a Taiwan-based API and finished-dose drug development company, and Vitruvias Therapeutics LLC, a generic drug development company, announced...
View ArticleCytori Strengthens Global Patent Portfolio
SAN DIEGO Cytori Therapeutics, Inc. (NASDAQ: CYTX) announced today a number of key additions to its patent portfolio in Japan and Europe. The company now has 85 global patents issued, 12 of which...
View ArticleMaterialise and Canon Lifecare Solutions Sign Distribution Agreement
LEUVEN, Belgium Materialise NV (NASDAQ:MTLS), is proud to announce the signing of an agreement that will see Canon Lifecare Solutions distributing software solutions from the Materialise Mimics...
View ArticleArticle 0
ロンドン (ビジネスワイヤ) — アストラゼネカは本日、非小細胞肺がん(NSCLC)患者のファーストライン治療およびセカンドライン治療の両方でオシメルチニブを検討する第1相延長試験の追跡データを、2016年欧州肺がん学会(ELCC)で発表しました。最新演題の発表内容はAURA臨床試験プログラムですでに示されたオシメルチニブの有効性/安全性プロファイルを補強するものでした。...
View ArticleAcucela Announces End of Treatment Period in Phase 2b/3 Clinical Trial of...
SEATTLE Acucela Inc. (Tokyo: 4589) (“Acucela”), a clinical-stage ophthalmology company that specializes in identifying and developing novel therapeutics to treat and slow the progression of...
View ArticleZEMBRACE™ SymTouch™ (Sumatriptan Injection) 3 mg, Approved by the FDA in...
HYDERABAD, India & PRINCETON, N.J. Promius Pharma LLC, a subsidiary of Dr. Reddy’s Laboratories (BSE: 500124, NSE: DRREDDY, NYSE: RDY), announced today that ZEMBRACE SymTouch is now commercially...
View Article美国临床肿瘤学会支持WIN 2016研讨会:以创新途径改善癌症患者治疗效果
法国维勒瑞夫 –(美国商业资讯)–WIN联合会(WIN)自豪地宣布,其致力于“以创新途径改善癌症患者治疗效果”研讨会已获得美国临床肿瘤学会(ASCO®)的支持,列为该学会的优秀科学项目。WIN主席、MD安德森个体化癌症疗法研究所所长John Mendelsohn说:“这是ASCO®连续第8年支持这一独特的科学论坛,该论坛已成为精准癌症医学领域的重要活动。” WIN...
View ArticleAmpliPhi Biosciences Provides Update on Phase I Trial: Phage Therapy Well...
SAN DIEGO AmpliPhi Biosciences Corporation (NYSEMKT: APHB), a global leader in the development of bacteriophage-based antibacterial therapies to treat drug-resistant infections, today provided an...
View ArticleAcucela to Present at ARVO 2016 Annual Meeting’s Education Courses in Seattle
SEATTLE Acucela Inc. (Tokyo: 4589) (“Acucela”), a clinical-stage ophthalmology company that specializes in identifying and developing novel therapeutics to treat and slow the progression of...
View Articleフランスの大学病院の1つがSpHb®、PVI®、SET®パルスオキシメトリーを搭載したマシモのRadical-7®を採用
スイス・ヌーシャテル (ビジネスワイヤ) — マシモ(NASDAQ:...
View Article甘峰健康听力中心有限公司成为贝尔通在香港、澳门和广东的独家经销商
丹麦巴勒鲁普 (美国商业资讯) –隶属于GN Hearing集团的贝尔通公司(Beltone A/S)75年来一直是听力保健领域的领导者,向市场提供先进的创新助听产品,包括世界上首台为iPhone (MFi)量身打造的助听器。该公司今天宣布,甘峰健康听力中心有限公司(KAM Hearing Health...
View Articleエボテックとエクセンシアがbispecific低分子腫瘍免疫薬の創薬での提携を発表
独ハンブルク & スコットランド・ダンディー (BUSINESS WIRE)– (ビジネスワイヤ) — エボテック(Frankfurt Stock Exchange: EVT、TecDAX、ISIN:...
View ArticlePerkinElmer and Genome Institute of Singapore Open Joint Research Laboratory...
WALTHAM, Mass. & SINGAPORE PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, and the Genome Institute of Singapore (GIS), a biomedical...
View Article